PCA
NVO

Prosperity Capital Advisors’s Novo Nordisk NVO Stock Holding History

Prosperity Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,526
Closed -$243K – 425
2025
Q2 		$243K Buy
3,526
+417
+13% +$28.4K 0.02% 357
2025
Q1 		$212K Sell
3,109
-14
-0.4% -$1.16K 0.02% 338
2024
Q4 		$269K Buy
3,123
+202
+7% +$21.8K 0.02% 297
2024
Q3 		$348K Buy
2,921
+41
+1% +$5.47K 0.03% 254
2024
Q2 		$411K Sell
2,880
-476
-14% -$63.1K 0.05% 215
2024
Q1 		$431K Buy
3,356
+844
+34% +$100K 0.05% 225
2023
Q4 		$260K Buy
2,512
+266
+12% +$26.3K 0.03% 221
2023
Q3 		$204K Buy
+2,246
New +$198K 0.03% 230

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prosperity Capital Advisors's NVO Position: Q3 2025 in Review

Prosperity Capital Advisors sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,526 shares — an estimated $243K sold.

Prosperity Capital Advisors first reported a position in NVO in Q3 2023 and held it in 8 quarters. The position peaked at $431K in Q1 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Prosperity Capital Advisors reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Prosperity Capital Advisors sold 3,526 Novo Nordisk shares in Q3 2025, an estimated $243K.
  • Prosperity Capital Advisors first reported a position in Novo Nordisk in Q3 2023 and held it in 8 quarters.
  • Prosperity Capital Advisors's Novo Nordisk position peaked at $431K in Q1 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Prosperity Capital Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.